• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Intrauterine Contraceptive Devices Market

    ID: MRFR/HC/13090-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Intrauterine Contraceptive Devices Market Research Report: By Type (Copper Intrauterine Devices, Hormonal Intrauterine Devices, Multi-Load Intrauterine Devices), By Material (Copper, Plastic, Hormonal), By Distribution Channel (Hospitals, Gynecology Clinics, Pharmacies) and By End User (Women of Reproductive Age, Healthcare Providers, Family Planning Organizations) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Intrauterine Contraceptive Devices Market Infographic
    Purchase Options

    US Intrauterine Contraceptive Devices Market Summary

    The US Intrauterine Contraceptive Devices market is projected to grow from 825.6 million USD in 2024 to 1347.5 million USD by 2035.

    Key Market Trends & Highlights

    US Intrauterine Contraceptive Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 4.55 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1347.5 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 825.6 million USD, reflecting a strong foundation for future expansion.
    • Growing adoption of intrauterine contraceptive devices due to increasing awareness of family planning is a major market driver.

    Market Size & Forecast

    2024 Market Size 825.6 (USD Million)
    2035 Market Size 1347.5 (USD Million)
    CAGR (2025-2035) 4.55%

    Major Players

    Hologic, Bayer, AstraZeneca, Santen Pharmaceutical, Merck, GlaxoSmithKline, KYG Holdings, Ferring Pharmaceuticals, Pfizer, Allergan, B Medical Systems, Johnson and Johnson, Mylan, Teva Pharmaceuticals

    US Intrauterine Contraceptive Devices Market Trends

    The US Intrauterine Contraceptive Devices Market is currently experiencing significant trends driven by a shift towards more effective and long-term contraceptive options. Increasing awareness about the benefits of intrauterine devices (IUDs), such as their efficiency and low maintenance, contributes to the rising preference among women. Healthcare providers are also advocating for IUDs due to their ability to provide reliable contraception without the need for daily compliance, tapping into the growing demand for user-friendly birth control methods.

    Additionally, new innovations in IUD technology and materials are emerging, which enhance user comfort and decrease side effects.The emergence of hormonal IUDs alongside traditional copper IUDs caters to a broader range of preferences among users, creating an expanded market. There is also an opportunity for educational initiatives aimed at both healthcare professionals and potential users to dispel myths and provide clear information on the safety and benefits of IUDs, thereby increasing adoption rates.

    The trend of increasing health insurance coverage, including provisions for reproductive health services, supports greater access to IUDs for women across diverse socio-economic backgrounds in the US. Furthermore, as states enhance access to family planning services, there is potential for the market to expand.Recently, the conversation around reproductive rights has intensified, influencing policies that could impact the availability and acceptance of contraceptive methods like IUDs. As the market continues to evolve, these trends indicate a promising future for the intrauterine contraceptive devices sector within the US.

    Market Segment Insights

    Intrauterine Contraceptive Devices Market Type Insights

    The US Intrauterine Contraceptive Devices Market segment classified by Type highlights the diverse options available to women seeking long-term contraceptive solutions. Copper Intrauterine Devices are recognized for their effectiveness and non-hormonal nature, making them a popular choice among women who prefer to avoid hormonal side effects. These devices prevent pregnancy primarily by creating a hostile environment for sperm and are widely acclaimed for their longevity, often providing protection for up to a decade.

    Hormonal Intrauterine Devices, on the other hand, release hormones to prevent ovulation and may lead to lighter menstrual periods, appealing to women looking for both contraceptive efficacy and menstrual management.This type often allows for personalized healthcare, as it suits a variety of needs and lifestyle choices. Multi-Load Intrauterine Devices are also gaining traction, often regarded as offering a tailored solution for larger families or those seeking flexible options.

    This variety in the Type segment caters to a broad demographic, encouraging healthy reproductive choices among women in the United States while reflecting the evolving nature of contraceptive technology. Factors driving the market growth include increased awareness about reproductive health options, the push for family planning in public health initiatives, and the desire for long-lasting, reliable contraception.

    The US Intrauterine Contraceptive Devices Market segmentation reveals how different types respond to varying consumer needs while addressing healthcare trends that prioritize personalized, effective family planning strategies. Each type of device plays a crucial role in expanding access to reproductive health services and educating women about their choices, ultimately supporting the ongoing conversations about women’s health in the United States.

    Intrauterine Contraceptive Devices Market Material Insights

    The US Intrauterine Contraceptive Devices Market has shown a notable trend towards diversification in its Material segment, comprising Copper, Plastic, and Hormonal IUDs. Copper IUDs are widely recognized for their efficacy as a non-hormonal contraceptive method, appealing to a segment of the population seeking alternatives to hormonal solutions. They are often favored due to their longer lifespan and the added benefit of being a non-systemic approach, which resonates well with health-conscious individuals.

    In contrast, Plastic and Hormonal IUDs provide users with options that offer additional health benefits, such as reducing menstrual pain and regulating menstrual cycles.The growing awareness of various contraceptive methods, along with increased healthcare accessibility in the US, is driving the adoption of these diverse materials. This segment's significance is further amplified due to its ability to cater to different user preferences and medical needs, thereby enhancing its share in the overall US Intrauterine Contraceptive Devices Market.

    With ongoing developments in this sector, the Material segment stands as a pivotal aspect in addressing the reproductive health requirements and choices of women across the United States.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Intrauterine Contraceptive Devices Market Distribution Channel Insights

    The Distribution Channel segment of the US Intrauterine Contraceptive Devices Market serves as a crucial component in delivering these reproductive health products to women across the nation. Hospitals play a significant role in this segment as they provide comprehensive care and access to trained healthcare professionals skilled in family planning. Gynecology clinics also hold an important position, offering specialized services that cater to women's health needs and ensuring personalized consultations for intrauterine contraceptive device insertion.Pharmacies contribute to the accessibility of these contraceptives, allowing patients to obtain their devices conveniently and often providing supplementary health information.

    The growing focus on women's reproductive rights and the increasing awareness of intrauterine contraceptive devices as a reliable form of long-term contraception are key drivers enhancing the importance of these distribution channels. The collaboration between these channels helps streamline access, thereby contributing to the overall growth of the US Intrauterine Contraceptive Devices Market.As the healthcare landscape evolves, the efficient distribution methods will continue to adapt, meeting the needs of a diverse population seeking effective contraceptive solutions.

    Intrauterine Contraceptive Devices Market End User Insights

    The End User segment of the US Intrauterine Contraceptive Devices Market plays a pivotal role in shaping the dynamics of the industry. Predominantly, Women of Reproductive Age represent a crucial demographic, driving the demand for effective contraceptive solutions, given their unique health needs and preferences for long-term family planning. Healthcare Providers, including clinics and hospitals, significantly influence the market through recommendations and access to these devices, facilitating education and supportive care for patients seeking reliable contraceptive options.Family Planning Organizations are instrumental in increasing awareness and accessibility, focusing on empowering women to make informed choices about their reproductive health.

    This segment's evolution is supported by a growing emphasis on women's health and rights, responding to shifting societal values and government initiatives aimed at enhancing reproductive healthcare access. Collectively, these user groups demonstrate a significant impact on market trends, adoption rates, and the overall growth of the US Intrauterine Contraceptive Devices Market, with ongoing efforts to enhance user experience and outcomes.

    Get more detailed insights about US Intrauterine Contraceptive Devices Market

    Key Players and Competitive Insights

    The competitive landscape of the US Intrauterine Contraceptive Devices Market has evolved significantly in recent years, driven by advancements in technology, regulatory changes, and an increasing awareness of reproductive health among women. Companies within this market are focusing on innovation and sustainability to capture market share and respond to diverse consumer needs. The introduction of various types of intrauterine devices, including hormonal and non-hormonal options, has broadened choices for consumers, leading to heightened competition among manufacturers.

    Additionally, marketing strategies and educational campaigns aimed at increasing awareness about the benefits and safety of intrauterine contraceptive devices have intensified with growing demand. As competition continues to evolve, companies must navigate regulatory environments while fostering partnerships and alliances to enhance their market position.

    Hologic

    Hologic has established itself as a strong player within the US Intrauterine Contraceptive Devices Market, significantly impacting the sector with its innovative products. Hologic's strength lies in its commitment to science and technology, which has allowed the company to develop and market various intrauterine devices that emphasize user safety and effectiveness. The company leverages its substantial research and development capabilities to keep ahead of the competition, focusing on product quality and patient outcomes.

    Hologic's existing infrastructure and distribution networks enable it to maintain a robust presence across numerous healthcare facilities, ensuring that healthcare providers and patients have access to its offerings. Hologic's strong branding, clinical support, and commitment to women's health also contribute to its reputation as a trusted entity in the market, fostering customer loyalty and brand recognition.

    Bayer

    Bayer remains a formidable competitor in the US Intrauterine Contraceptive Devices Market, renowned for its well-established product portfolio and innovative solutions. The company provides numerous key products, including hormonal IUDs that cater to varying consumer preferences and reproductive health needs. Bayer has invested significantly in research and development, resulting in devices that not only enhance contraceptive efficacy but also support long-term reproductive health outcomes. The company's presence is complemented by strategic mergers and acquisitions that have bolstered its market position and expanded its product offerings.

    Bayer emphasizes partnerships within the healthcare sector, enhancing its ability to reach diverse demographics and address varying healthcare needs. Additionally, Bayer is involved in educational initiatives aimed at increasing awareness of IUDs, further establishing its position as a trusted leader within the US Intrauterine Contraceptive Devices Market.

    Key Companies in the US Intrauterine Contraceptive Devices Market market include

    Industry Developments

    The US Intrauterine Contraceptive Devices Market has seen significant developments recently, highlighted by ongoing product innovations and regulatory updates from major companies such as Hologic, Bayer, and Merck. For instance, in March 2023, Merck received FDA approval for their new intrauterine device, which has enhanced the competitive landscape. Additionally, Hologic reported a 15% growth in their sales of Intrauterine Contraceptive Devices in Q2 2023, reflecting the rising consumer preference for long-acting reversible contraception.

    The market is also witnessing increased investments in Research and Development by companies like AstraZeneca and GlaxoSmithKline, focusing on expanding product offerings and improving device safety profiles. No notable mergers or acquisitions have been reported recently in this segment, but the presence of established players like Johnson and Johnson and Pfizer remains strong, contributing to market stability. The overall market valuation is expected to continue to rise, supported by growing awareness of contraceptive options and campaigns promoting women's health in the US, particularly in urban and underserved areas.

    These factors are essential in shaping the current landscape of the Intrauterine Contraceptive Devices Market in the United States.

    Market Segmentation

    Intrauterine Contraceptive Devices Market Type Outlook

    • Copper Intrauterine Devices
    • Hormonal Intrauterine Devices
    • Multi-Load Intrauterine Devices

    Intrauterine Contraceptive Devices Market End User Outlook

    • Women of Reproductive Age
    • Healthcare Providers
    • Family Planning Organizations

    Intrauterine Contraceptive Devices Market Material Outlook

    • Copper
    • Plastic
    • Hormonal

    Intrauterine Contraceptive Devices Market Distribution Channel Outlook

    • Hospitals
    • Gynecology Clinics
    • Pharmacies

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 791.35(USD Million)
    MARKET SIZE 2024 825.65(USD Million)
    MARKET SIZE 2035 1347.5(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.554% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Hologic, Bayer, AstraZeneca, Santen Pharmaceutical, Merck, GlaxoSmithKline, KYG Holdings, Ferring Pharmaceuticals, Pfizer, Allergan, B Medical Systems, Johnson and Johnson, Mylan, Teva Pharmaceuticals
    SEGMENTS COVERED Type, Material, Distribution Channel, End User
    KEY MARKET OPPORTUNITIES Increased awareness of contraceptive options, Rising demand for long-term solutions, Growth in telehealth and remote consultations, Expansion of product offerings and innovations, Enhanced access in underserved regions
    KEY MARKET DYNAMICS rising adoption rates, government policy support, increasing healthcare expenditure, awareness of contraceptive options, technological advancements
    COUNTRIES COVERED US

    FAQs

    What is the market size of the US Intrauterine Contraceptive Devices Market in 2024?

    The market size of the US Intrauterine Contraceptive Devices Market is expected to be valued at 825.65 million USD in 2024.

    What is the projected market value for the US Intrauterine Contraceptive Devices Market by 2035?

    By 2035, the US Intrauterine Contraceptive Devices Market is projected to reach a value of 1347.5 million USD.

    What is the expected CAGR for the US Intrauterine Contraceptive Devices Market from 2025 to 2035?

    The expected CAGR for the US Intrauterine Contraceptive Devices Market from 2025 to 2035 is 4.554%.

    What are the main types of intrauterine contraceptive devices in the market?

    The main types of intrauterine contraceptive devices are Copper Intrauterine Devices, Hormonal Intrauterine Devices, and Multi-Load Intrauterine Devices.

    Which type of intrauterine device is expected to have the highest market value in 2035?

    The Hormonal Intrauterine Devices are expected to have the highest market value, projected at 590.0 million USD in 2035.

    Who are the key players in the US Intrauterine Contraceptive Devices Market?

    Major players in the market include Hologic, Bayer, AstraZeneca, Santen Pharmaceutical, Merck, and GlaxoSmithKline.

    What is the estimated market value of Copper Intrauterine Devices in 2024?

    The estimated market value of Copper Intrauterine Devices in 2024 is 300.0 million USD.

    What challenges are facing the US Intrauterine Contraceptive Devices Market?

    Challenges in the market include regulatory pressures, competition from alternative contraceptive methods, and pricing pressures.

    What are the growth drivers for the US Intrauterine Contraceptive Devices Market?

    Growth drivers include rising awareness of contraceptive options, increasing preference for long-acting reversible contraceptives, and improving healthcare infrastructure.

    What are the projected market values for Multi-Load Intrauterine Devices in 2035?

    The projected market value for Multi-Load Intrauterine Devices in 2035 is 267.5 million USD.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials